Previous 10 | Next 10 |
Gainers: Synlogic (NASDAQ: SYBX ) +28% . Immuron (NASDAQ: IMRN ) +26% . B Communications (NASDAQ: BCOM ) +23% . Arcadia Biosciences (NASDAQ: RKDA ) +17% . Vuzix Corporation (NASDAQ: VUZI ) +14% . MagnaChip Semiconductor Corporation (NYSE: MX ) +13% . Osmotica Pharmaceuticals (N...
That's all the freedom we can hope for - the freedom to choose our prison. " - L.M. Montgomery, The Blue Castle The market finally broke a six-week losing streak last week. A punk Jobs Report on Friday confirmed the most likely next move from the Federal Reserve is an interest rate cut. T...
Gainers: Obalon Therapeutics (NASDAQ: OBLN ) +42% . Eltek (NASDAQ: ELTK ) +35% . SilverSun Technologies (NASDAQ: SSNT ) +33% . MiMedx Group ( OTC:MDXG ) +31% . BioCryst Pharmaceuticals (NASDAQ: BCRX ) +19% . Tocagen (NASDAQ: TOCA ) +17% . Hydrogenics Corporation (NASDAQ: HYGS )...
SAN DIEGO , May 30, 2019 /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced Marty Duvall , chief executive officer, will present at the Jefferies 2019 Healthcare Conference on Thursday, June 6 , at 4:00 p.m. ET ...
Gainers: Novan (NASDAQ: NOVN ) +27% . Sea Limited (NYSE: SE ) +23% . Allied Healthcare Products (NASDAQ: AHPI ) +17% . Westwater Resources (NASDAQ: WWR ) +12% . Novus Therapeutics (NASDAQ: NVUS ) +12% . Spherix Incorporated (NASDAQ: SPEX ) +11% . CSW Industrials (NASDAQ: CSWI )...
OncoSec Medical (NASDAQ: ONCS ) -31% on pricing equity offering. More news on: OncoSec Medical Incorporated, Ekso Bionics Holdings, Inc., Tocagen Inc., Stocks on the move, Read more ...
Gainers: CVI +3.7% . PVH +3.2% . More news on: CVR Energy, Inc., PVH Corp., Tocagen Inc., Stocks on the move, Read more ...
Apparently expecting better news, investors head for the exits after Tocagen (NASDAQ: TOCA ) reported that its Phase 3 clinical trial, Toca 5 , evaluating Toca 511 & Toca FC in patients with recurrent high grade glioma will continue without modification. The decision was based on a pr...
SAN DIEGO , May 21, 2019 /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced the Toca 5 Phase 3 clinical trial evaluating Toca 511 & Toca FC in patients with recurrent high grade glioma (HGG) continues without mo...
Tocagen (NASDAQ: TOCA ): Q1 GAAP EPS of -$0.74 beats by $0.03 . Cash and equivalents of $80.1M. Press Release More news on: Tocagen Inc., Earnings news and commentary, Healthcare stocks news, ,
News, Short Squeeze, Breakout and More Instantly...
Tocagen Company Name:
TOCA Stock Symbol:
NASDAQ Market:
SAN DIEGO , May 28, 2020 /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), historically a clinical-stage, cancer-selective gene therapy company, announced today that, due to public health and safety concerns related to the COVID-19 global pandemic, recommendations and orders from federal, stat...
SAN DIEGO , April 23, 2020 /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), historically a clinical-stage, cancer-selective gene therapy company, today reported financial results for the first quarter ended March 31, 2020 . On February 19, 2020 , Tocagen announced it ha...
Speculation & News Are Driving Momentum For These Penny Stocks If there’s one thing we’ve learned from penny stocks it’s that speculation can make for exciting times. While these cheap stocks are already volatile and high risk, events like the novel coronavirus or COVI...